- Home
- / Chongqing Lummy Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Chongqing Lummy Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥4.1
2024-10-29
Market Capitalization
¥4.2 B
2024-10-29
Revenue
¥748.2 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.5B | 1.8B | 1.6B | 1.2B | 848.3M | 854.8M | 764.5M | 748.2M |
| Cost of goods sold | 612.5M | 524.9M | 505.3M | 349.6M | 234.4M | 274.7M | 283.3M | 343.1M |
| Gross profit | 921.2M | 1.3B | 1.1B | 850.9M | 633.0M | 601.5M | 494.3M | 418.8M |
| Gross profit margin, % | 72.1% | 67.8% | 71.8% | 74.6% | 70.4% | 64.6% | 56.0% | |
| Operating expense total | 679.4M | 1.2B | 1.1B | 891.5M | 675.8M | 612.2M | 530.4M | 440.2M |
| Depreciation and amortization | 107.8M | 189.3M | 274.7M | 69.4M | 70.6M | 65.4M | 75.8M | 106.6M |
| EBITDA | 238.4M | 80.3M | (21.9M) | (37.5M) | (38.9M) | (35.6M) | (56.1M) | (43.3M) |
| EBITDA margin, % | 4.4% | -1.4% | -3.2% | -4.6% | -4.2% | -7.3% | -5.8% | |
| EBIT | 129.6M | (87.6M) | (262.1M) | (134.4M) | (76.2M) | (106.0M) | (75.5M) | (135.6M) |
| EBIT margin, % | -4.8% | -16.9% | -11.3% | -9.0% | -12.4% | -9.9% | -18.1% | |
| Interest income | 2.1M | 4.3M | 6.4M | 13.5M | 12.9M | 34.6M | 29.7M | 24.8M |
| Interest expense | 57.9M | 72.3M | 83.2M | 32.1M | 20.3M | 12.5M | 11.1M | 13.8M |
| Pre tax profit | 109.3M | (169.7M) | (343.6M) | (106.0M) | (75.2M) | 3.6M | (75.5M) | (146.8M) |
| Income tax expense | 18.2M | (8.3M) | 1.1M | (27.0K) | 1.0M | 13.6M | 4.6M | (20.3M) |
| Net Income | 91.1M | (161.4M) | (344.7M) | (105.9M) | (76.3M) | (10.0M) | (80.1M) | (126.5M) |